TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34781969

Group type: EXPERIMENTAL
Intervention: On-the-spot pregnancy test (N=170)
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Future-use pregnancy test (N=163)
Number of subjects: 810

Group type: EXPERIMENTAL
Intervention: Both on-the-spot and future-use pregnancy tests (N=153)
Number of subjects: 810

Group type: COMPARATOR
Intervention: Control group (N=324)
Number of subjects: 810
Study: 32526606

Group type: EXPERIMENTAL
Intervention: Midwifery continuity of care
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 18
Study: 616569131

Group type: EXPERIMENTAL
Intervention: Proximal Femoral Nail 'antirotation' (PFNa)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Sliding Hip Screw (SHS)
Number of subjects: 140
Study: 35357105

Group type: EXPERIMENTAL
Intervention: Lactobacillus casei (1 × 10^10 CFU/day)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Lactobacillus casei (2 × 10^10 CFU/day)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Standard antituberculosis therapy only (Control group)
Number of subjects: 47
Study: 34330608

Group type: EXPERIMENTAL
Intervention: Condylar apex method
Number of subjects: 93

Group type: COMPARATOR
Intervention: Condylar centre method
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: 3D reconstruction of the TMJ structure
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Comparison of disc position between genders
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Comparison of left and right TMJ disc–condyle position
Number of subjects: 93
Study: 33580673

Group type: COMPARATOR
Intervention: Variants at six loci associated with SSS including a missense variant in MYH6 and variants at PITX2, ZFHX3, TTN/CCDC141, SCN10A, and KRT8.
Number of subjects: 6469

Group type: COMPARATOR
Intervention: Mendelian randomization analysis for AF and lower heart rate.
Number of subjects: 6469

Group type: COMPARATOR
Intervention: Powerful PGS analyses.
Number of subjects: 6469
Study: 32505382

Group type: EXPERIMENTAL
Intervention: Embryo diagnostics
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rigorous validation of embryo diagnostics
Number of subjects: 0
Study: 36123843

Group type: EXPERIMENTAL
Intervention: Dexamethasone injection preoperatively
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Honey locally in the wound after extraction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dexamethasone injection preoperatively and topical honey application
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Group IV (Dexamethasone and honey)
Number of subjects: 0
Study: 34032731

Group type: EXPERIMENTAL
Intervention: Puerarin (150 mg/d for 3 months)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Standard treatment (Diane-35, 1 tablet/d, orally, plus metformin, 1.5 g/d, orally)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Standard treatment plus puerarin
Number of subjects: 51
Study: 32783667

Group type: EXPERIMENTAL
Intervention: CDK4/6 inhibitors (CDK4/6i)
Number of subjects: 88
Study: 35752175

Group type: EXPERIMENTAL
Intervention: Video educational intervention prior to simulation-1 (n=83)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Video educational intervention between simulation-1 and simulation-2 (n=83)
Number of subjects: 166
Study: 32797375

Group type: EXPERIMENTAL
Intervention: Bifidobacterium lactis BS01 and Lactobacillus acidophilus LA02 supplementation
Number of subjects: 53

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 53
Study: 35089372

Group type: COMPARATOR
Intervention: 0.9% NaCl (Group I)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: lidocaine 0.25 mg/kg (Group II)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: lidocaine 0.5 mg/kg (Group III)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: lidocaine 1.0 mg/kg (Group IV)
Number of subjects: 320
Study: 33049411

Group type: EXPERIMENTAL
Intervention: Oral TXA (1 g at 4, 10, and 16 hours postoperatively)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Intravenous TXA (0.5 g at 6, 12, and 18 hours postoperatively)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 35987548

Group type: EXPERIMENTAL
Intervention: Accept Yourself! (AY)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Weight Watchers (WW)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both groups (AY and WW)
Number of subjects: 19
Study: 32057988

Group type: EXPERIMENTAL
Intervention: ARPF
Number of subjects: 77

Group type: COMPARATOR
Intervention: ORIF
Number of subjects: 77
Study: 35020796

Group type: EXPERIMENTAL
Intervention: 200,000 IU vitamin D3
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200
Study: 34304322

Group type: EXPERIMENTAL
Intervention: PGPR strain Mn‐6
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: EPS‐producing PGPR (various strains)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (non‐inoculated treatment)
Number of subjects: 0
Study: 32658327

Group type: EXPERIMENTAL
Intervention: Patients with higher seizure frequencies and lower standard deviations during their baseline
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Typical trial design with patients included
Number of subjects: 0

Group type: COMPARATOR
Intervention: Typical trial design without patients included
Number of subjects: 0
Study: 33814186

Group type: EXPERIMENTAL
Intervention: Two stage Fowler-Stephens laparoscopic orchiopexy (FSLO)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Staged laparoscopic traction orchiopexy (SLTO)
Number of subjects: 45
Study: 32064975

Group type: EXPERIMENTAL
Intervention: 0.04% tretinoin microspheres plus 1% clindamycin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 33998778

Group type: EXPERIMENTAL
Intervention: Water-based Liuzijue exercise (WG)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Land-based Liuzijue exercise (LG)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 50
Study: 32057275

Group type: EXPERIMENTAL
Intervention: Digital Whole Slide Imaging (WSI)
Number of subjects: 2045

Group type: COMPARATOR
Intervention: Light Microscopy (glass slides)
Number of subjects: 2045
Study: 35593710

Group type: EXPERIMENTAL
Intervention: Burr Hole Craniostomy (BHC)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Minicraniotomy (MC)
Number of subjects: 245

Group type: EXPERIMENTAL
Intervention: Twist Drill Craniostomy (TDC)
Number of subjects: 245
Study: 33331008

Group type: EXPERIMENTAL
Intervention: EBI-OTM
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: EBI-LS
Number of subjects: 3

Group type: COMPARATOR
Intervention: CI
Number of subjects: 3
Study: 32824995

Group type: EXPERIMENTAL
Intervention: Childhood maltreatment (physical abuse)
Number of subjects: 21019

Group type: EXPERIMENTAL
Intervention: Childhood maltreatment (emotional abuse)
Number of subjects: 21019

Group type: EXPERIMENTAL
Intervention: Childhood maltreatment (sexual abuse)
Number of subjects: 21019

Group type: EXPERIMENTAL
Intervention: Childhood maltreatment (physical neglect)
Number of subjects: 21019

Group type: EXPERIMENTAL
Intervention: Childhood maltreatment (emotional neglect)
Number of subjects: 21019

Group type: EXPERIMENTAL
Intervention: Childhood maltreatment
Number of subjects: 21019
Study: 36437383

Group type: EXPERIMENTAL
Intervention: 10 mg rosuvastatin plus 10 mg ezetimibe
Number of subjects: 12

Group type: COMPARATOR
Intervention: 10 mg rosuvastatin alone
Number of subjects: 12

Group type: COMPARATOR
Intervention: 10 mg ezetimibe alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 10 mg ezetimibe plus 10 mg rosuvastatin
Number of subjects: 12
Study: 34101900

Group type: EXPERIMENTAL
Intervention: Calcifediol 0.266 mg/month for 12 months
Number of subjects: 303

Group type: COMPARATOR
Intervention: Cholecalciferol 25,000 IU/month for 12 months
Number of subjects: 303

Group type: EXPERIMENTAL
Intervention: Calcifediol 0.266 mg/month for 4 months followed by placebo for 8 months
Number of subjects: 303
Study: 32912942

Group type: EXPERIMENTAL
Intervention: Probiotic Peanut Oral ImmunoTherapy (PPOIT)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 200

Group type: COMPARATOR
Intervention: Peanut OIT alone
Number of subjects: 200
Study: 36268671

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Treatment-as-Usual (TAU)
Number of subjects: 130
Study: 35046656

Group type: EXPERIMENTAL
Intervention: Jingxin Zhidong Formula (JXZDF) 17.6 g/day
Number of subjects: 120

Group type: COMPARATOR
Intervention: aripiprazole 10 mg/day
Number of subjects: 120
Study: 33203026

Group type: EXPERIMENTAL
Intervention: Regularized Randomized Neural Network (RRNN)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Kernel Ridge Regression Neural Network (KRR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional support vector machine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Extreme learning based solutions
Number of subjects: 0
Study: 35977701

Group type: EXPERIMENTAL
Intervention: Water birth
Number of subjects: 120

Group type: COMPARATOR
Intervention: Conventional birth
Number of subjects: 120
Study: 33475230

Group type: EXPERIMENTAL
Intervention: Biopsy threshold of prostate-specific antigen > 3.0
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Biopsy threshold of > 15% from the European Randomized Study of Screening for Prostate Cancer calculator
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: Biopsy threshold of > 5% risk
Number of subjects: 144
Study: 32869069

Group type: EXPERIMENTAL
Intervention: Enhanced oropharyngeal suctioning every 4 hours
Number of subjects: 513

Group type: COMPARATOR
Intervention: Sham suctioning
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Patients intubated at another hospital and transferred
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Patients intubated in the field
Number of subjects: 513
Study: 36286922

Group type: EXPERIMENTAL
Intervention: Raphamin
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 34887283

Group type: EXPERIMENTAL
Intervention: Culturally tailored Diabetes Self-Management Education (DSME) program
Number of subjects: 4000000

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 4000000
Study: 32359361

Group type: EXPERIMENTAL
Intervention: Music therapy intervention (seven-day programme including music sessions)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Therapeutic education (seven sessions of spoken word)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Music therapy intervention
Number of subjects: 81
Study: 35614277

Group type: EXPERIMENTAL
Intervention: app‐assisted interactive power toothbrush (PTB‐A)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: non-app‐assisted interactive power toothbrush (PTB‐NA)
Number of subjects: 90

Group type: COMPARATOR
Intervention: manual toothbrush (MTB)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: both PTBs (PTB‐A and PTB‐NA)
Number of subjects: 90
Study: 33770392

Group type: EXPERIMENTAL
Intervention: Tafamidis
Number of subjects: 441

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 441
Study: 32367867

Group type: EXPERIMENTAL
Intervention: Ondansetron 4 mg (Group O)
Number of subjects: 109

Group type: EXPERIMENTAL
Intervention: Tramadol 50 mg (Group T)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Saline 4 ml (Group S)
Number of subjects: 109
Study: 34636271

Group type: EXPERIMENTAL
Intervention: Worksheet exercise to enhance reporting behavior
Number of subjects: 503
Study: 32040523

Group type: EXPERIMENTAL
Intervention: Family economic empowerment (EE) intervention
Number of subjects: 288

Group type: COMPARATOR
Intervention: Non-intervention group
Number of subjects: 288

Group type: EXPERIMENTAL
Intervention: Higher number of medications per day
Number of subjects: 288
Study: 34166033

Group type: EXPERIMENTAL
Intervention: 6 mg nicotine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 12 mg nicotine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34414154

Group type: EXPERIMENTAL
Intervention: Healthy for my Baby intervention
Number of subjects: 68

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 68
Study: 35357762

Group type: EXPERIMENTAL
Intervention: AE + BFR (aerobic exercise with blood flow restriction)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: HIAE (high-intensity aerobic exercise)
Number of subjects: 22

Group type: COMPARATOR
Intervention: AE (aerobic exercise without BFR)
Number of subjects: 22

Group type: COMPARATOR
Intervention: CON (non-exercise control condition)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: HIAE
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: AE + BFR
Number of subjects: 22

Group type: COMPARATOR
Intervention: AE
Number of subjects: 22

Group type: COMPARATOR
Intervention: CON
Number of subjects: 22
Study: 33892046

Group type: EXPERIMENTAL
Intervention: CXL plus standard care
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 60
Study: 32769878

Group type: EXPERIMENTAL
Intervention: AZL‐M 80 mg
Number of subjects: 612

Group type: EXPERIMENTAL
Intervention: AZL‐M 40 mg
Number of subjects: 612

Group type: COMPARATOR
Intervention: valsartan 160 mg
Number of subjects: 612
Study: 36357159

Group type: EXPERIMENTAL
Intervention: Indobufen
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 33722866

Group type: EXPERIMENTAL
Intervention: Free distribution of medicines
Number of subjects: 268
Study: 32718515

Group type: EXPERIMENTAL
Intervention: Web-based virtual animated health counselor intervention
Number of subjects: 528
Study: 33253678

Group type: EXPERIMENTAL
Intervention: Culprit‐lesion‐only PCI
Number of subjects: 667

Group type: COMPARATOR
Intervention: CTO presence
Number of subjects: 667
Study: 32325257

Group type: EXPERIMENTAL
Intervention: 5 days of filgrastim
Number of subjects: 466

Group type: COMPARATOR
Intervention: 7/10 days of filgrastim
Number of subjects: 466
Study: 35631300

Group type: EXPERIMENTAL
Intervention: MCT supplementation (n = 9)
Number of subjects: 17

Group type: COMPARATOR
Intervention: No supplementation (n = 8)
Number of subjects: 17
Study: 33640577

Group type: EXPERIMENTAL
Intervention: Nomogram for Overall Survival (OS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nomogram for Freedom from Locoregional Recurrence (FFLR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nomogram for Freedom from Distant Metastasis (FFDM)
Number of subjects: 0
Study: 34652086

Group type: EXPERIMENTAL
Intervention: Tai Chi
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Iyengar Yoga
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control Group (General Education)
Number of subjects: 48
Study: 32736216

Group type: EXPERIMENTAL
Intervention: Combined exercise training (aerobic and Pilates training, 3 sessions per week for 8 weeks)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Combined exercise training
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control Group (relaxation exercises at home)
Number of subjects: 34
Study: 34930617

Group type: EXPERIMENTAL
Intervention: veliparib during chemotherapy and maintenance (veliparib-throughout)
Number of subjects: 1132

Group type: EXPERIMENTAL
Intervention: veliparib during chemotherapy followed by placebo maintenance (veliparib-combination only)
Number of subjects: 1132

Group type: COMPARATOR
Intervention: placebo during chemotherapy and maintenance (control)
Number of subjects: 1132
Study: 32096571

Group type: EXPERIMENTAL
Intervention: Tofogliflozin
Number of subjects: 419

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 419
Study: 35179587

Group type: EXPERIMENTAL
Intervention: PROTECT intervention group
Number of subjects: 422

Group type: COMPARATOR
Intervention: Assessment-only control group
Number of subjects: 422
Study: 33911032

Group type: EXPERIMENTAL
Intervention: Greenlight intervention
Number of subjects: 865

Group type: COMPARATOR
Intervention: Attention-control arm
Number of subjects: 865
Study: 32854752

Group type: EXPERIMENTAL
Intervention: 3-session psychoeducational intervention (n = 60)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (n = 60)
Number of subjects: 120
Study: 34775283

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Health education (HE) control
Number of subjects: 54
Study: 32678285

Group type: EXPERIMENTAL
Intervention: Anodal cerebellar transcranial direct current stimulation (ctDCS)
Number of subjects: 30
Study: 36341232

Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Standard-care (low FODMAP diet, Otilonium Bromide 1 tablet TID, multi-strain probiotic 1 capsule BID for 1 month)
Number of subjects: 59
Study: 34028790

Group type: EXPERIMENTAL
Intervention: Modified CART algorithm for local disease (I)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modified CART algorithm for ≤3 positive nodes (II)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modified CART algorithm for ≥4 positive nodes (III)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Modified CART algorithm for presence of distant metastases (IV)
Number of subjects: 0
Study: 35500316

Group type: EXPERIMENTAL
Intervention: n-3 PUFAs group (EN combined with PN enriched with n-3 PUFAs from postoperative Day 1 to Day 5)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (EN combined with PN without n-3 PUFAs)
Number of subjects: 120
Study: 33246489

Group type: EXPERIMENTAL
Intervention: UCB+EPO
Number of subjects: 88

Group type: COMPARATOR
Intervention: UCB+placebo EPO
Number of subjects: 88

Group type: COMPARATOR
Intervention: placebo UCB+EPO
Number of subjects: 88

Group type: COMPARATOR
Intervention: placebo UCB+placebo EPO
Number of subjects: 88
Study: 36067479

Group type: EXPERIMENTAL
Intervention: dHACA plus Standard of Care (SOC)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Weekly dHACA plus SOC
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Biweekly dHACA plus SOC
Number of subjects: 60

Group type: COMPARATOR
Intervention: Standard of Care (SOC)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Adverse Events (AEs)
Number of subjects: 60
Study: 34261526

Group type: EXPERIMENTAL
Intervention: Allogenic FMT (screened and processed donor stool)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Autologous FMT (their own stool)
Number of subjects: 0
Study: 35705354

Group type: EXPERIMENTAL
Intervention: High-definition transcranial infraslow pink noise stimulation (HD-tIPNS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 40
Study: 34034036

Group type: EXPERIMENTAL
Intervention: Inspiratory Muscle Training (IMT)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 40
Study: 33985435

Group type: EXPERIMENTAL
Intervention: Severe chemotherapy-induced neutropenia (CIN)
Number of subjects: 1529

Group type: EXPERIMENTAL
Intervention: Mild chemotherapy-induced neutropenia (CIN)
Number of subjects: 1529

Group type: EXPERIMENTAL
Intervention: Severe and mild chemotherapy-induced neutropenia (CIN) in out-of-landmark group
Number of subjects: 1529
Study: 32133902

Group type: EXPERIMENTAL
Intervention: Information and communication technology system for pain management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 34242412

Group type: EXPERIMENTAL
Intervention: Proposed approach for sample size estimation using frailty models
Number of subjects: 0

Group type: COMPARATOR
Intervention: Existing methods for sample size estimation
Number of subjects: 0
Study: 33183883

Group type: EXPERIMENTAL
Intervention: Low FODMAP diet (LFD)
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation
Number of subjects: 95

Group type: COMPARATOR
Intervention: Sham diet
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 35410754

Group type: EXPERIMENTAL
Intervention: Selumetinib granule (25 mg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Selumetinib capsule (50 mg [2 x 25 mg])
Number of subjects: 24

Group type: COMPARATOR
Intervention: Both formulations
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Granule formulation
Number of subjects: 24
Study: 32720695

Group type: EXPERIMENTAL
Intervention: Isoniazid preventive therapy (IPT)
Number of subjects: 944

Group type: COMPARATOR
Intervention: QuantiFERON-gold-in-tube (QGIT)
Number of subjects: 944

Group type: COMPARATOR
Intervention: Tuberculin skin test (TST)
Number of subjects: 944
Study: 36075073

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 290
Study: 32994594

Group type: EXPERIMENTAL
Intervention: budesonide/formoterol Turbuhaler 200/6mcg one actuation as required
Number of subjects: 890

Group type: COMPARATOR
Intervention: budesonide Turbuhaler 200mcg one actuation twice daily and terbutaline Turbuhaler 250mcg two actuations as required
Number of subjects: 890
Study: 35864051

Group type: EXPERIMENTAL
Intervention: Prehospital plasma
Number of subjects: 501

Group type: COMPARATOR
Intervention: Control (REF group)
Number of subjects: 501
Study: 34380643

Group type: EXPERIMENTAL
Intervention: Ibrutinib 420 mg once daily
Number of subjects: 31
Study: 33202607

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet-based intervention (MedDiet supplemented with Extra Virgin Olive Oil/pistachios)
Number of subjects: 544

Group type: COMPARATOR
Intervention: Control group (CG) recommended to limit fat intake
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Real-world group (RW) applying IG recommendations
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: Mediterranean Diet-based intervention (MedDiet)
Number of subjects: 544
Study: 33301613

Group type: EXPERIMENTAL
Intervention: Ravulizumab every 8 weeks
Number of subjects: 191

Group type: COMPARATOR
Intervention: Eculizumab followed by ravulizumab
Number of subjects: 191
Study: 33499376

Group type: EXPERIMENTAL
Intervention: Dietary counseling focused on dietary fat quality (n = 108)
Number of subjects: 1062

Group type: COMPARATOR
Intervention: Control group (n = 124)
Number of subjects: 1062
Study: 34687308

Group type: EXPERIMENTAL
Intervention: Dry needling with conventional physical therapy
Number of subjects: 69

Group type: COMPARATOR
Intervention: Sham dry needling with conventional physical therapy
Number of subjects: 69

Group type: COMPARATOR
Intervention: Conventional physical therapy (control group)
Number of subjects: 69